Pierre Fabre launches unique project giving access to its huge plant library

8 December 2015
pierre-fabre-medicament-logo-big

Pharma companies looking to developing innovative treatments from natural products will be given access to the world’s largest private collection of plants thanks to a unique project launched by French company Pierre Fabre.

From today, Pierre Fabre will allow access to its plant library – Nature Open Library - to help its partners boost innovative projects which involve the development and formulation of plant active ingredients. The library houses more than 15,000 dry plant samples from 7,000 species, some of which are very rare.

François Sautel, project manager for Nature Open Library, said: “We own the biggest private collection of plants in the world which has allowed us to develop numerous treatments dedicated to cancer research and dermatology. We have become aware of the far greater potential this collection has if we make it available to others. We wish to offer our partners the chance to take advantage of this opportunity in their research by using our collection of plant samples and to help them develop or even industrialize any of their findings.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Today's issue

Company Spotlight





More Features in Pharmaceutical